10 FDA consultants

Seven of these FDA consultants worked inside the agency, as an investigator, a compliance officer, a lead reviewer, a regulatory scientist, a supervisory chemist and senior leaders, and their consulting splits between medical device submissions such as 510(k), PMA, De Novo and IVD applications and drug and biologic quality compliance. They suit a company preparing a first device clearance, answering an FDA-483 or getting ready for a manufacturing inspection.

10 professionals10 companiesData retrieved September 29, 2026

Professionals to explore

  1. Colleen Hoyt

    LinkedIn

    Experience: Owner & Principal Consultant · PharmQ Strategy Lab, LLC

    Describing themselves as a "Former FDA Inspectorate Leader," Colleen Hoyt became Owner & Principal Consultant at PharmQ Strategy Lab, LLC in 2026. Hoyt's FDA titles were Branch Director, Pharmaceutical Quality Programs, OPQO, ORA (2020-2025), Staff Director, ORA Team Biologics (2010-2020) and Consumer Safety Officer, CDER Office of Compliance (2003-2010), so drug and biologic inspection questions fit best.

    Is this you? Claim your profile and get paid for calls.

  2. Hu Jinjie

    LinkedIn

    Experience: Senior Consultant · Biologics Consulting Group, Inc.

    Hu Jinjie was a Senior Regulatory Scientist at the FDA from 2001 to 2012 and has been a Senior Consultant at Biologics Consulting Group, Inc. since 2012, focused on IVD devices. In their own words, the work includes "Advising you on the regulatory requirements for your IVD product" and developing IVD applications, which makes Hu the person here for diagnostics submissions.

    Is this you? Claim your profile and get paid for calls.

  3. John Gillespy

    LinkedIn

    Experience: President · FDA 510k Consulting, LLC

    John Gillespy has been President of FDA 510k Consulting, LLC since 2011, a firm that helps device manufacturers, importers, repackagers and relabelers bring new products to the U.S. market and specializes in the 510(k) Premarket Notification pathway. Gillespy was also Chief Financial & Regulatory Officer at Denterprise International Inc (2011-2015), so 510(k) planning questions fit best.

    Is this you? Claim your profile and get paid for calls.

  4. Johnny Guerra

    LinkedIn

    Experience: FDA Regulatory Consultant President · GUERRA CONSULTING GROUP, INC.

    After years at the FDA as Supervisory Chemist (1990-1999) and Computer Specialist (1986-1990), Johnny Guerra has been FDA Regulatory Consultant President at GUERRA CONSULTING GROUP, INC. since 1999. The firm provides "FDA-related consulting, auditing, training and validation regulatory compliance services" to pharmaceutical, API, biotechnology, device and cosmetic companies, so audit and validation questions fit.

    Is this you? Claim your profile and get paid for calls.

  5. José E. Cabrera

    LinkedIn

    Experience: Principal Consultant - Owner Operator · De Novo MedTech FDA Consulting

    Since 2020, José E. Cabrera has been Principal Consultant - Owner Operator at De Novo MedTech FDA Consulting, covering regulatory strategy, quality management system implementation, design change management, FDA reporting and post-market surveillance for device companies. Cabrera was Vice President of Regulatory Affairs and Quality Assurance at Heraeus Medical Components (2019-2020) and at Somahlution (2014-2018).

    Is this you? Claim your profile and get paid for calls.

  6. Lynne Ensor

    LinkedIn

    Experience: President Owner Regulatory Consultant · Ensor Pharma Biotech Consulting

    Lynne Ensor describes being an "Ex-FDA Senior Leader" and has been President Owner Regulatory Consultant at Ensor Pharma Biotech Consulting since 2025 and Partner at ELIQUENT Life Sciences since 2026. Ensor's other titles include Senior Global Managing Director and Vice President, Pharma Biotech Consulting at NSF (2024-2025) and Senior Vice President, Head of Global Strategic Compliance Consulting at Parexel (2022-2024).

    Is this you? Claim your profile and get paid for calls.

  7. Martina LaGrange

    LinkedIn

    Experience: Principal · FDA Compliance Group LLC

    Martina LaGrange was a Consumer Safety Officer, Investigator at the Food & Drug Administration (1989-2003), describing 14 years as an FDA investigator in the Seattle and Denver District Offices and work as an FDA Medical Device Specialist. LaGrange has been Principal at FDA Compliance Group LLC since 2007, whose specialties include FDA-483 responses, Warning Letter responses, 510k and PMA submissions.

    Is this you? Claim your profile and get paid for calls.

  8. Megan Shackelford

    LinkedIn

    Experience: Regulatory Affairs Consultant, Medical Devices · Shackelford Consulting Services, LLC

    Megan Shackelford, a former lead reviewer in the FDA's Gastroenterology and Renal Devices Branch, has been Regulatory Affairs Consultant, Medical Devices at Shackelford Consulting Services, LLC since 2025, specializing in 510(k)s, PMAs, IDEs, Q-submissions and de novos. Shackelford was Principal Consultant, Regulatory Affairs at Avania (2023-2025) and Principal Regulatory Affairs Specialist at Biolinq (2022-2023).

    Is this you? Claim your profile and get paid for calls.

  9. Regina Barrell

    LinkedIn

    Experience: Principal Owner · Stonecroft Consulting, LLC

    With "over 28 years with the FDA," Regina Barrell held Senior Case Review Expert (2008-2015), Compliance Officer (2001-2008 and 1992-1999) and Supervisory Consumer Safety Officer (2000-2001) titles there. Barrell has been Principal Owner of Stonecroft Consulting, LLC since 2016, advising pharmaceutical, medical device, food and dietary supplement companies, a fit for compliance case review questions.

    Is this you? Claim your profile and get paid for calls.

  10. Susan Anthoney-DeWet

    LinkedIn

    Experience: FDA Regulatory Consultant · FDA Regulatory Consultants, LLC

    Susan Anthoney-DeWet has been an FDA Regulatory Consultant at FDA Regulatory Consultants, LLC since 2019 and was an FDA Consultant at Aegis Regulatory, Inc from 2009 to 2019, specializing in medical devices, cosmetics and radiation-emitting products. Anthoney-DeWet lists 21 CFR 820 quality systems, ISO 13485, 21 CFR 801 labeling and 21 CFR 1000-1040 electronic products, a fit for quality system and labeling questions.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

For a device submission, Megan Shackelford, Martina LaGrange, John Gillespy and Hu Jinjie (IVD products) are the closest fits, with Susan Anthoney-DeWet for quality systems and labeling on devices, cosmetics and radiation-emitting products. Drug and biologic inspection readiness points to Colleen Hoyt, Lynne Ensor, Regina Barrell or Johnny Guerra, while José E. Cabrera suits quality system and post-market questions from an industry regulatory affairs background.

Questions to take into the conversation

  1. 01When should a device company request an FDA pre-submission meeting, and what should it bring to get useful feedback?
  2. 02How should a manufacturer respond to an FDA-483 so that it does not turn into a Warning Letter?
  3. 03What do FDA investigators look for first when they inspect a drug or biologics manufacturing site?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals